AngioDynamics, Inc.
$10.79
▼
-13.65%
2026-04-21 05:18:01
www.angiodynamics.com
NMS: ANGO
Explore AngioDynamics, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$449.55 M
Current Price
$10.79
52W High / Low
$13.99 / $8.36
Stock P/E
—
Book Value
$4.16
Dividend Yield
—
ROCE
-11.8%
ROE
-17.47%
Face Value
—
EPS
$-0.76
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
675
Beta
0.43
Debt / Equity
6.57
Current Ratio
2.35
Quick Ratio
1.4
Forward P/E
-44.55
Price / Sales
1.29
Enterprise Value
$382.07 M
EV / EBITDA
-579.77
EV / Revenue
1.22
Rating
Strong Buy
Target Price
$18
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Retractable Technologies, Inc. | $0.65 | — | $19.46 M | 1.18% | -10.73% | -15.56% | $1.14 / $0.62 | $2.48 |
| 2. | Milestone Scientific Inc. | $0.29 | — | $23.33 M | — | -155% | -1.32% | $1.11 / $0.22 | $0.04 |
| 3. | Nyxoah SA | $3.23 | — | $121.16 M | — | -119.32% | -1.11% | $8.87 / $2.35 | $1.33 |
| 4. | Solventum Corporation | $69.51 | 7.83 | $12.08 B | — | 5.66% | 38.86% | $88.2 / $62.38 | $29.1 |
| 5. | OraSure Technologies, Inc. | $3.19 | — | $221.2 M | — | -18.75% | -18.3% | $3.82 / $2.08 | $4.84 |
| 6. | Cuprina Holdings (Cayman) Limited | $0.33 | — | $2.47 M | — | 34.48% | -1.39% | $9.5 / $0.28 | $0.28 |
| 7. | ICU Medical, Inc. | $130.58 | 4,461.76 | $3.27 B | — | 3.08% | 0.04% | $160.29 / $107 | $86.03 |
Quarterly Results
Figures shown in M / B
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|
| Sales | 78.42 M | 79.43 M | 75.71 M | 80.16 M | 72 M | — | — |
| Operating Profit | -6.43 M | -2.49 M | -7.9 M | -3.63 M | -6.65 M | — | — |
| Net Profit | -8.08 M | -6.35 M | -10.9 M | -6.05 M | -4.41 M | — | — |
| EPS in Rs | -0.2 | -0.15 | -0.26 | -0.15 | -0.11 | -0.26 | -0.31 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 292.5 M | 303.91 M | 338.75 M | 316.22 M |
| Operating Profit | -24.06 M | -33.84 M | -18.68 M | -18.22 M |
| Net Profit | -33.99 M | -184.35 M | -52.44 M | -26.55 M |
| EPS in Rs | -0.82 | -4.46 | -1.27 | -0.64 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 280.14 M | 317.67 M | 532.64 M | 552.75 M |
| Total Liabilities | 97.17 M | 112.08 M | 154.34 M | 128.26 M |
| Equity | 182.97 M | 205.59 M | 378.3 M | 424.49 M |
| Current Assets | 168.32 M | 193.25 M | 163.54 M | 143.34 M |
| Current Liabilities | 76.2 M | 91.16 M | 83.83 M | 74.32 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -10.13 M | -28.16 M | 0.08 M | -7.19 M |
| Investing CF | -10.18 M | 123.72 M | -9.75 M | -19.31 M |
| Financing CF | -0.26 M | -64.25 M | 25.42 M | 7.68 M |
| Free CF | -14.59 M | -33.93 M | -4.27 M | -11.49 M |
| Capex | -4.46 M | -5.77 M | -4.35 M | -4.3 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -10.28% | 7.13% | — | — |
| Earnings Growth % | -251.53% | -97.54% | — | — |
| Profit Margin % | -60.66% | -15.48% | -8.4% | — |
| Operating Margin % | -11.14% | -5.51% | -5.76% | — |
| Gross Margin % | 50.9% | 51.44% | 52.41% | — |
| EBITDA Margin % | -2.02% | 3.6% | 3.52% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.